Copyright: © 2024 Published by Elsevier Ltd. By definition, rare diseases affect a small number of individuals (fewer than 1 in 2000 people in any WHO region); yet ...
Berlin (ots) - Der Deutsche Krebskongress (DKK) gilt als eines der wichtigsten Foren für Onkologie im deutschsprachigen Raum. Beim 37. Kongress in Berlin stehen erneut neue Strategien im Kampf gegen ...
It's that time of year again... the season of the never-ending sickness bug. As we slog through February and desperately wait for spring, it seems that literally everyone is still sick. And it's no ...
Although it feels like many of us are only just hearing about it, adenovirus has officially earned the title of this season's 'mystery illness' – and that tracks, given how many of our WhatsApp group ...
Researchers identify genetic mutation in small group of people who developed the serious disorder after receiving the AstraZeneca or Johnson & Johnson vaccine. About one in 200,000 people developed ...
A global research collaboration of scientists from McMaster University (Canada), Flinders University (Australia) and Universitätsmedizin Greifswald (Germany) uncovered why a small number of people ...
In all patients, results of a platelet factor 4 (PF4)–induced platelet-activation (PIPA) assay were strongly positive, and serum from all the patients tested strongly positive against PF4 alone in a ...
Abstract: Gene therapies have shown great promise for the potential treatment of a broad range of diseases. Adeno-associated viruses (AAVs) are popular gene vectors because of their ability to target ...
A highly contagious, mysterious illness is continuing to sweep the UK this week, government data warns. The illness, known as adenovirus, can cause stomach flu or vomiting in more severe cases. As ...
Changsha (China). Seit geraumer Zeit liegen Hinweise vor, dass die Wirkung einer Krebsimmuntherapie davon beeinflusst wird, zu welcher Tageszeit (ToD, „time of day“) sie erfolgt. Die bisherige ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results